Brent Standridge

All filings by Brent Standridge on record concern Aratana Therapeutics, Inc. In total, 5 filings cover trades dated from 1 July 2016 to 25 June 2018.

The open-market record consists of 2 sales worth €91k, with no purchase. Outside the open market, there are 3 share grants. So far in 2018, the count stands at no purchases and 1 sale.

The latest filing, published on 27 June 2018, reports an open-market sale of €39k in Aratana Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.